based on 15 analysts
73.33%
Buy
20.00%
Hold
6.67%
Sell
Based on 15 analysts offering long term price targets for Fortis Healthcare Ltd. An average target of ₹543.2
Source: S&P Global Market Intelligence
Fortis Healthcare Ltd price forecast by 15 analysts
Downside of
High
₹595
Target
₹543.20
Low
₹490
Fortis Healthcare Ltd target price ₹543.2, a slight downside of -8.39% compared to current price of ₹590.5. According to 15 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Fortis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:25.16%
Forecast
Actual
Including amortisation and stock based compensations
Fortis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2026:72.89%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 13.33 % |
3 Month Return | + 21.12 % |
1 Year Return | + 76.08 % |
Market Stats | |
Previous Close | ₹592.95 |
Open | ₹591.00 |
Volume | 14.16L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹44,765.24Cr |
P/E Ratio | 68.55 |
PEG Ratio | 69.95 |
Market Cap | ₹44,765.24 Cr |
P/B Ratio | 3.49 |
EPS | 8.55 |
Dividend Yield | 0.24 |
Sector | Healthcare |
ROE | 1.37 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹44,765.24 Cr | 74.12% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
BUY | ₹93,611.46 Cr | 152.34% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
BUY | ₹1,01,165.45 Cr | 79.61% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
BUY | ₹26,032.50 Cr | 89.39% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
BUY | ₹21,807.57 Cr | 34.67% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Organisation | Fortis Healthcare Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Fortis Healthcare Ltd
Fortis Healthcare shares rose 1% to Rs. 572.40. Aster DM Healthcare reported a 12.16% YoY revenue growth in Q1FY25, reaching Rs. 1,859 Crores, with profits increasing from Rs. 124 Crores to Rs. 174 Crores.
Fortis Healthcare Shares Rise on GST Cut Announcement - 10 Sep, 2024
Shares of Fortis Healthcare increased by 3% to Rs 563.55 following the Finance Minister's announcement to reduce GST on cancer drugs from 12% to 5%.
Fortis to Boost Stake in Agilus Diagnostics - 04 Sep, 2024
Fortis Healthcare plans to acquire an additional 31.8% stake in Agilus Diagnostics for ₹1,778 crore, increasing its ownership to approximately 88%. The acquisition will be funded through non-convertible debentures, following a put option exercise by private equity investors.
Fortis Healthcare Reaches 52-Week High on Acquisition News - 02 Sep, 2024
Fortis Healthcare's stock surged to a 52-week high of Rs 565.65 after announcing plans to acquire a 31.52% stake in Agilus Diagnostics. The acquisition will be funded through Non-Convertible Debentures. The company reported a 40.4% increase in Q1FY25 net profit, indicating strong financial performance.
Fortis Healthcare Stock Hits Record High Amid Strong Trading - 30 Aug, 2024
Fortis Healthcare's stock surged to an all-time high of Rs 563 on August 30, 2024, driven by heavy trading volumes and positive financial performance. The board is also set to discuss a share buyback and fundraising proposal.
Fortis Hospital Launches Self-Defence Training for Female Staff - 29 Aug, 2024
Fortis Hospital in Delhi has initiated a week-long self-defence training program for its female medical staff, training over 600 members in response to a recent incident. The program includes various self-defence techniques and has been positively received by participants eager to enhance their safety.
Fortis Hospital Launches Self-Defense Training for Staff - 28 Aug, 2024
Fortis Hospital Shalimar Bagh, in collaboration with Delhi Police, has initiated a seven-day self-defense training program for female medical staff to enhance their safety and empowerment following a tragic incident involving a trainee doctor.
Fortis Healthcare Reports Growth and Buy Recommendation - 27 Aug, 2024
HDFC Securities recommends buying Fortis Healthcare with a target price of Rs 646. The company reported a 4.25% increase in total income and a net profit of Rs 173.39 crore for the latest quarter.
Fortis Healthcare Reports Strong Revenue Growth - 25 Aug, 2024
Fortis Healthcare reported a 12.2% increase in revenue to Rs 1,859 crore, driven by significant growth in cardiac sciences and oncology services. The company is enhancing its service offerings, focusing on complex and specialized procedures that command higher prices.
Political Crisis in Bangladesh Affects Fortis Healthcare - 23 Aug, 2024
The political turmoil in Bangladesh has led to a significant decline in medical tourism for Fortis Healthcare, with patient visits dropping by up to 50%. The company remains hopeful for recovery as the situation stabilizes.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 1.69K Cr → 1.87K Cr (in ₹), with an average increase of 4.8% per quarter
Best in 1 Year
In the last 1 year, FORTIS has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Price Rise
In the last 7 days, FORTIS stock has moved up by 2.9%
FII Holding Up
Foreign Institutions have increased holdings from 23.24% to 23.31% in Jun 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 26.51% to 27.52% in Jun 2024 quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 158.0% return, outperforming this stock by 30.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 31.17% of holdings in Jun 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 178.73 Cr → 165.96 Cr (in ₹), with an average decrease of 7.1% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 14.45% to 13.21% in Jun 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 31.17% | 0.00 | |
Foreign Institutions | 23.31% | 0.31 | |
Mutual Funds | 27.52% | 3.80 | |
Retail Investors | 13.21% | ||
Others | 4.79% | 3.33 |
Fortis Healthcare Ltd in the last 5 years
Lowest (-166.21x)
June 25, 2021
Today (68.55x)
September 18, 2024
Industry (96.56x)
September 18, 2024
Highest (165.13x)
April 9, 2020
Fortis Healthcare Ltd’s net profit jumped 48.5% since last year same period to ₹165.96Cr in the Q1 2024-2025. On a quarterly growth basis, Fortis Healthcare Ltd has generated -7.14% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Fortis Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.34%.
Read More about DividendsBearish
Neutral
Bullish
Fortis Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Fortis Healthcare Ltd (FORTIS) share price today is ₹590.5
Fortis Healthcare Ltd is listed on NSE
Fortis Healthcare Ltd is listed on BSE
PE Ratio of Fortis Healthcare Ltd is 68.55
PE ratio = Fortis Healthcare Ltd Market price per share / Fortis Healthcare Ltd Earnings per share
Today’s traded volume of Fortis Healthcare Ltd(FORTIS) is 14.16L.
Today’s market capitalisation of Fortis Healthcare Ltd(FORTIS) is ₹44765.24Cr.
Fortis Healthcare Ltd(FORTIS | Price |
---|---|
52 Week High | ₹609.95 |
52 Week Low | ₹313.8 |
Fortis Healthcare Ltd(FORTIS) share price is ₹590.5. It is down -3.19% from its 52 Week High price of ₹609.95
Fortis Healthcare Ltd(FORTIS) share price is ₹590.5. It is up 88.18% from its 52 Week Low price of ₹313.8
Fortis Healthcare Ltd(FORTIS | Returns |
---|---|
1 Day Returns | -2.45% |
1 Month Returns | 13.33% |
3 Month Returns | 21.12% |
1 Year Returns | 76.08% |